Michael Lacy

606 total citations
9 papers, 323 citations indexed

About

Michael Lacy is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Michael Lacy has authored 9 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Michael Lacy's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Immune cells in cancer (2 papers). Michael Lacy is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Immune cells in cancer (2 papers). Michael Lacy collaborates with scholars based in Germany, Netherlands and United States. Michael Lacy's co-authors include Dorothee Atzler, Katrin Nitz, Christian Weber, Menno P.J. de Winther, Esther Lutgens, Yvonne Döring, Emiel P. C. van der Vorst, Selin Gencer, Kimberly A. Harris and Brian D. Nicholas and has published in prestigious journals such as Journal of Neuroscience, Scientific Reports and European Heart Journal.

In The Last Decade

Michael Lacy

9 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Lacy Germany 7 121 101 40 40 37 9 323
Franziska Hartung Germany 10 109 0.9× 215 2.1× 63 1.6× 30 0.8× 12 0.3× 13 362
Dheeraj Soni United States 12 187 1.5× 195 1.9× 20 0.5× 42 1.1× 63 1.7× 19 519
Indiwari Gopallawa United States 10 39 0.3× 82 0.8× 35 0.9× 38 0.9× 34 0.9× 13 303
Sarah McGrath Sweden 10 65 0.5× 72 0.7× 27 0.7× 13 0.3× 15 0.4× 14 333
Xiaofang Yang China 8 88 0.7× 71 0.7× 19 0.5× 45 1.1× 30 0.8× 21 233
Valentina Carlini Italy 9 105 0.9× 112 1.1× 11 0.3× 52 1.3× 28 0.8× 15 375
Marion Brollo France 12 108 0.9× 112 1.1× 8 0.2× 47 1.2× 69 1.9× 23 464
Junqing An United States 11 92 0.8× 125 1.2× 26 0.7× 53 1.3× 51 1.4× 17 376
Stephanie Cicalese United States 11 56 0.5× 170 1.7× 41 1.0× 47 1.2× 36 1.0× 20 398

Countries citing papers authored by Michael Lacy

Since Specialization
Citations

This map shows the geographic impact of Michael Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lacy more than expected).

Fields of papers citing papers by Michael Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lacy. The network helps show where Michael Lacy may publish in the future.

Co-authorship network of co-authors of Michael Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lacy. A scholar is included among the top collaborators of Michael Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lacy. Michael Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lacy, Michael, et al.. (2023). T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease. Cells. 12(17). 2152–2152. 29 indexed citations
2.
Lacy, Michael, Aleksandar Janjic, Katrin Nitz, et al.. (2023). The role of EZH2 and H3K27me3 epigenetic signature in modulating T-cell polarization in atherosclerosis. European Heart Journal. 44(Supplement_2). 1 indexed citations
3.
Wichapong, Kanin, Michael Lacy, Katrin Nitz, et al.. (2023). Atheroprotective CD40-TRAF6 inhibitors: translational pipeline towards a clinical application. European Heart Journal. 44(Supplement_2). 1 indexed citations
4.
Gencer, Selin, Michael Lacy, Dorothee Atzler, et al.. (2020). Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thrombosis and Haemostasis. 120(12). 1629–1641. 42 indexed citations
5.
Bianchini, Mariaelvy, Johan Duchêne, Donato Santovito, et al.. (2019). PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function. Science Immunology. 4(36). 44 indexed citations
6.
Nitz, Katrin, Michael Lacy, & Dorothee Atzler. (2019). Amino Acids and Their Metabolism in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 39(3). 319–330. 68 indexed citations
7.
Lacy, Michael, et al.. (2018). Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis. Pharmacology & Therapeutics. 193. 50–62. 43 indexed citations
8.
Lacy, Michael, Christos K. Kontos, Kathleen Hille, et al.. (2018). Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4. Scientific Reports. 8(1). 5171–5171. 38 indexed citations
9.
Francis, Shimon P., Joshua S. Katz, Kimberly A. Harris, et al.. (2013). A Novel Role of Cytosolic Protein Synthesis Inhibition in Aminoglycoside Ototoxicity. Journal of Neuroscience. 33(7). 3079–3093. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026